Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Proton Therapy for Locally Advanced Breast Cancer with a Focus on Cardiac Benefits

24/02/2023
/ Webinar

Shannon MacDonald covers one of proton therapy's growing indications: breast cancer. In her talk, she focuses on locally advanced breast cancer and cardiac...

DynamicARC: the Future of Proton Therapy

24/02/2023
/ Webinar
/
ARC therapy

DynamicARC® proton therapy is one of the most promising developments in proton radiation therapy, as it allows dynamic irradiation while the gantry is rotating...

Conventional versus hypofractionated postmastectomy proton radiotherapy in the USA (MC1631): a randomised phase 2 trial.

23/11/2023
/ Publications

Published in the Lancet Oncology, this randomized phase 2 study by the Mayo group was set to compare conventional fractionated (50 Gy in 25 fractions of 2 Gy)...

Reconstructive complications and early toxicity in breast cancer patients treated with proton-based postmastectomy radiation therapy.

01/03/2024
/ Publications

This study compared acute toxicities and reconstructive complications in patients treated with proton-based (n = 11)and photon-based PMRT (n = 26). Grade 2 skin...

Outcomes of Patients Treated in the UK Proton Overseas Programme: Non-central Nervous System Group.

01/03/2024
/ Publications

This report presented the results of patients with non-CNS malignancies treated in the UK proton overseas program. Four hundred and ninety-five patients were...

Future Perspectives of Proton Therapy in Minimizing the Toxicity of Breast Cancer Radiotherapy.

16/05/2021
/ Publications
/
Dosimetry
Reirradiation
Toxicity

A review article compared the clinical evidence including the parameters of the dose distribution in organs at risk, such as the heart, blood vessels, and lungs...

Proton Therapy for Partial Breast Irradiation: Rationale and Considerations.

16/04/2021
/ Publications
/
Reirradiation

A review specifically for PBT partial breast irradiation. This review found that tumor control with PT is excellent, and the toxicities associated with PT PBI...

A retrospective study of adjuvant proton radiotherapy for breast cancer after lumpectomy: a comparison of conventional-dose and hypofractionated dose.

16/03/2023
/ Publications
/
Dosimetry
Hypofractionation
Toxicity

Fifty patients were treated with PT using two different regimens following lumpectomy. 14 patients received IMPT to a total dose of 50 Gy in 25 fractions...

The Potential of Proton Therapy for Locally Advanced Breast Cancer: Clinical and Technical Considerations.

16/02/2023
/ Publications
/
Toxicity

This review presented the rationale of using protons in the setting of locally advanced breast cancer, which is to mitigate treatment related toxicity...

Postmastectomy Intensity Modulated Proton Therapy: 5-Year Oncologic and Patient-Reported Outcomes.

16/11/2023
/ Publications
/
IMPT

127 patients received unilateral conventionally fractionated postmastectomy IMPT. Median follow-up was 4.1 years. Five-year LRC was 98.4% and OS was 87.9%...